Pregabalin的全球市場 2022-2026

Pregabalin的市場規模，預計從2022年～2026年之間增加1億5303萬美元，在預測期間內以3.74％的年複合成長率成長。

本報告提供Pregabalin市場整體分析，市場規模、預測，趨勢，成長促進因素、課題，網羅了約25家供應商的供應商分析等資訊。

提供目前全球市場趨勢與推動因素、市場整體環境的最新分析。由於有關神經病變性疼痛的大規模患者群存在，老年人口增加，各種疾病中Pregabalin的用途增加，牽引市場。

目錄

第1章 摘要整理

• 市場概要

第2章 市場形勢

• 市場生態系統

第3章 市場規模

• 市場定義
• 市場區隔分析
• 市場規模 2021
• 市場預測:2021-2026年的預測

第4章 波特的五力分析

• 五力的摘要
• 買方議價能力
• 供給企業談判力
• 新加入業者的威脅
• 替代品的威脅
• 競爭的威脅
• 市場情況

第5章 各應用領域市場區隔

• 市場明細
• 各用途比較
• 神經性疼痛 - 市場規模與預測 2021-2026
• 癲癇 - 市場規模與預測 2021-2026
• 焦慮症 - 市場規模與預測 2021-2026
• 其他 - 市場規模與預測 2021-2026
• 各應用領域的市場機會

第6章 客戶形勢

• 客戶形勢概要

第7章 各地區形勢

• 各地區市場區隔
• 各地區比較
• 北美 - 市場規模與預測 2021-2026
• 歐洲 - 市場規模與預測 2021-2026
• 亞洲 - 市場規模與預測 2021-2026
• 其他地區(ROW) - 市場規模與預測 2021-2026
• 美國 - 市場規模與預測 2021-2026
• 德國 - 市場規模與預測 2021-2026
• 加拿大 - 市場規模與預測 2021-2026
• 中國 - 市場規模與預測 2021-2026
• 日本 - 市場規模與預測 2021-2026
• 大韓民國 - 市場規模與預測 2021-2026
• 各地區形勢的市場機會

第8章 原動力，課題，及趨勢

• 推動市場要素
• 市場課題
• 推動要素與課題的影響
• 市場趨勢

第9章 業者情勢

• 概要
• 業者情勢
• 混亂狀況
• 產業的風險

第10章 供應商分析

• 交易廠商
• 供應商的市場定位
• Biomax Biotechnics Pvt. Ltd.
• Camber Pharmaceuticals Inc.
• Cipla Ltd.
• Genesis Biotec Inc.
• Lupin Ltd
• Medley Pharmaceuticals Ltd.
• MK Medicine
• Novartis AG
• Pfizer Inc.
• Torrent Pharmaceuticals Ltd.

第11章 附錄

Technavio has been monitoring the pregabalin market and it is poised to grow by $153.03 mn during 2022-2026, accelerating at a CAGR of 3.74% during the forecast period. Our report on the pregabalin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the presence of a large patient pool related to neuropathic pain, an increasing geriatric population, and rising applications of pregabalin in various diseases.

The pregabalin market analysis includes the application segment and geographic landscape.

Technavio's pregabalin market is segmented as below:

By Application

• Neuropathic pain
• Epilepsy
• Anxiety disorders
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing focus on emerging economies as one of the prime reasons driving the pregabalin market growth during the next few years. Also, increasing incidence of diabetes and HIV and rising healthcare expenditure will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the pregabalin market covers the following areas:

• Pregabalin market sizing
• Pregabalin market forecast
• Pregabalin market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pregabalin market vendors that include Biomax Biotechnics Pvt. Ltd., Camber Pharmaceuticals Inc., Cipla Ltd., Dr. Kumars Pharmaceuticals, Genesis Biotec Inc., H. L. Healthcare Pvt. Ltd., Lupin Ltd, Medley Pharmaceuticals Ltd., MK Medicine, MSN Laboratories, Neuracle Lifesciences Pvt. Ltd., Novartis AG, Pfizer Inc., Phoenix Biologicals Pvt. Ltd., Sun Pharmaceutical Industries Ltd, Swastik Life Sciences, Torrent Pharmaceuticals Ltd., and Vibcare Pharma Pvt. Ltd. Also, the pregabalin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary - Chart on Incremental Growth
• Exhibit 07: Executive Summary - Data Table on Incremental Growth
• Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 12: Market segments
• 3.3 Market size 2021
• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

• 5.1 Market segments
• Exhibit 24: Chart on Application - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
• 5.2 Comparison by Application
• Exhibit 26: Chart on Comparison by Application
• Exhibit 27: Data Table on Comparison by Application
• 5.3 Neuropathic pain - Market size and forecast 2021-2026
• Exhibit 28: Chart on Neuropathic pain - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Neuropathic pain - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Neuropathic pain - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Neuropathic pain - Year-over-year growth 2021-2026 (%)
• 5.4 Epilepsy - Market size and forecast 2021-2026
• Exhibit 32: Chart on Epilepsy - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Epilepsy - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Epilepsy - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Epilepsy - Year-over-year growth 2021-2026 (%)
• 5.5 Anxiety disorders - Market size and forecast 2021-2026
• Exhibit 36: Chart on Anxiety disorders - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Anxiety disorders - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Anxiety disorders - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Anxiety disorders - Year-over-year growth 2021-2026 (%)
• 5.6 Others - Market size and forecast 2021-2026
• Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
• 5.7 Market opportunity by Application
• Exhibit 44: Market opportunity by Application ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• 7.2 Geographic comparison
• Exhibit 48: Chart on Geographic comparison
• Exhibit 49: Data Table on Geographic comparison
• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• 7.7 US - Market size and forecast 2021-2026
• Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• 7.9 Canada - Market size and forecast 2021-2026
• Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• 7.10 China - Market size and forecast 2021-2026
• Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
• 7.11 Japan - Market size and forecast 2021-2026
• Exhibit 82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 84: Chart on Japan - Year-over-year growth 2021-2026 (%)
• Exhibit 85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
• 7.12 Republic of Korea - Market size and forecast 2021-2026
• Exhibit 86: Chart on Republic of Korea - Market size and forecast 2021-2026 ($ million)
• Exhibit 87: Data Table on Republic of Korea - Market size and forecast 2021-2026 ($ million)
• Exhibit 88: Chart on Republic of Korea - Year-over-year growth 2021-2026 (%)
• Exhibit 89: Data Table on Republic of Korea - Year-over-year growth 2021-2026 (%)
• 7.13 Market opportunity By Geographical Landscape
• Exhibit 90: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers
• 8.2 Market challenges
• 8.3 Impact of drivers and challenges
• Exhibit 91: Impact of drivers and challenges in 2021 and 2026
• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview
• 9.2 Vendor landscape
• Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
• 9.3 Landscape disruption
• Exhibit 93: Overview on factors of disruption
• 9.4 Industry risks
• Exhibit 94: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 95: Vendors covered
• 10.2 Market positioning of vendors
• Exhibit 96: Matrix on vendor position and classification
• 10.3 Biomax Biotechnics Pvt. Ltd.
• Exhibit 97: Biomax Biotechnics Pvt. Ltd. - Overview
• Exhibit 98: Biomax Biotechnics Pvt. Ltd. - Product / Service
• Exhibit 99: Biomax Biotechnics Pvt. Ltd. - Key offerings
• 10.4 Camber Pharmaceuticals Inc.
• Exhibit 100: Camber Pharmaceuticals Inc. - Overview
• Exhibit 101: Camber Pharmaceuticals Inc. - Product / Service
• Exhibit 102: Camber Pharmaceuticals Inc. - Key offerings
• 10.5 Cipla Ltd.
• Exhibit 103: Cipla Ltd. - Overview
• Exhibit 104: Cipla Ltd. - Business segments
• Exhibit 105: Cipla Ltd. - Key news
• Exhibit 106: Cipla Ltd. - Key offerings
• Exhibit 107: Cipla Ltd. - Segment focus
• 10.6 Genesis Biotec Inc.
• Exhibit 108: Genesis Biotec Inc. - Overview
• Exhibit 109: Genesis Biotec Inc. - Product / Service
• Exhibit 110: Genesis Biotec Inc. - Key offerings
• 10.7 Lupin Ltd
• Exhibit 111: Lupin Ltd - Overview
• Exhibit 112: Lupin Ltd - Product / Service
• Exhibit 113: Lupin Ltd - Key news
• Exhibit 114: Lupin Ltd - Key offerings
• 10.8 Medley Pharmaceuticals Ltd.
• Exhibit 115: Medley Pharmaceuticals Ltd. - Overview
• Exhibit 116: Medley Pharmaceuticals Ltd. - Product / Service
• Exhibit 117: Medley Pharmaceuticals Ltd. - Key offerings
• 10.9 MK Medicine
• Exhibit 118: MK Medicine - Overview
• Exhibit 119: MK Medicine - Product / Service
• Exhibit 120: MK Medicine - Key offerings
• 10.10 Novartis AG
• Exhibit 121: Novartis AG - Overview
• Exhibit 122: Novartis AG - Business segments
• Exhibit 123: Novartis AG - Key offerings
• Exhibit 124: Novartis AG - Segment focus
• 10.11 Pfizer Inc.
• Exhibit 125: Pfizer Inc. - Overview
• Exhibit 126: Pfizer Inc. - Product / Service
• Exhibit 127: Pfizer Inc. - Key news
• Exhibit 128: Pfizer Inc. - Key offerings
• 10.12 Torrent Pharmaceuticals Ltd.
• Exhibit 129: Torrent Pharmaceuticals Ltd. - Overview
• Exhibit 130: Torrent Pharmaceuticals Ltd. - Business segments
• Exhibit 131: Torrent Pharmaceuticals Ltd. - Key offerings
• Exhibit 132: Torrent Pharmaceuticals Ltd. - Segment focus

11 Appendix

• 11.1 Scope of the report
• 11.2 Inclusions and exclusions checklist
• Exhibit 133: Inclusions checklist
• Exhibit 134: Exclusions checklist
• 11.3 Currency conversion rates for US$
• Exhibit 135: Currency conversion rates for US$
• 11.4 Research methodology
• Exhibit 136: Research methodology
• Exhibit 137: Validation techniques employed for market sizing
• Exhibit 138: Information sources
• 11.5 List of abbreviations
• Exhibit 139: List of abbreviations
  • Population
  • pressure
  • in incidence rate

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Application
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Vendor Market Positioning
• Exhibits9: Parent market
• Exhibits10: Market Characteristics
• Exhibits11: Offerings of vendors included in the market definition
• Exhibits12: Market segments
• Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits17: Five forces analysis - Comparison between 2021 and 2026
• Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
• Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
• Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
• Exhibits23: Chart on Market condition - Five forces 2021 and 2026
• Exhibits24: Chart on Application - Market share 2021-2026 (%)
• Exhibits25: Data Table on Application - Market share 2021-2026 (%)
• Exhibits26: Chart on Comparison by Application
• Exhibits27: Data Table on Comparison by Application
• Exhibits28: Chart on Neuropathic pain - Market size and forecast 2021-2026 ($ million)
• Exhibits29: Data Table on Neuropathic pain - Market size and forecast 2021-2026 ($ million)
• Exhibits30: Chart on Neuropathic pain - Year-over-year growth 2021-2026 (%)
• Exhibits31: Data Table on Neuropathic pain - Year-over-year growth 2021-2026 (%)
• Exhibits32: Chart on Epilepsy - Market size and forecast 2021-2026 ($ million)
• Exhibits33: Data Table on Epilepsy - Market size and forecast 2021-2026 ($ million)
• Exhibits34: Chart on Epilepsy - Year-over-year growth 2021-2026 (%)
• Exhibits35: Data Table on Epilepsy - Year-over-year growth 2021-2026 (%)
• Exhibits36: Chart on Anxiety disorders - Market size and forecast 2021-2026 ($ million)
• Exhibits37: Data Table on Anxiety disorders - Market size and forecast 2021-2026 ($ million)
• Exhibits38: Chart on Anxiety disorders - Year-over-year growth 2021-2026 (%)
• Exhibits39: Data Table on Anxiety disorders - Year-over-year growth 2021-2026 (%)
• Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
• Exhibits44: Market opportunity by Application ($ million)
• Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits48: Chart on Geographic comparison
• Exhibits49: Data Table on Geographic comparison
• Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
• Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
• Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits78: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibits79: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibits80: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibits81: Data Table on China - Year-over-year growth 2021-2026 (%)
• Exhibits82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibits83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibits84: Chart on Japan - Year-over-year growth 2021-2026 (%)
• Exhibits85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
• Exhibits86: Chart on Republic of Korea - Market size and forecast 2021-2026 ($ million)
• Exhibits87: Data Table on Republic of Korea - Market size and forecast 2021-2026 ($ million)
• Exhibits88: Chart on Republic of Korea - Year-over-year growth 2021-2026 (%)
• Exhibits89: Data Table on Republic of Korea - Year-over-year growth 2021-2026 (%)
• Exhibits90: Market opportunity By Geographical Landscape ($ million)
• Exhibits91: Impact of drivers and challenges in 2021 and 2026
• Exhibits92: Overview on Criticality of inputs and Factors of differentiation
• Exhibits93: Overview on factors of disruption
• Exhibits94: Impact of key risks on business
• Exhibits95: Vendors covered
• Exhibits96: Matrix on vendor position and classification
• Exhibits97: Biomax Biotechnics Pvt. Ltd. - Overview
• Exhibits98: Biomax Biotechnics Pvt. Ltd. - Product / Service
• Exhibits99: Biomax Biotechnics Pvt. Ltd. - Key offerings
• Exhibits100: Camber Pharmaceuticals Inc. - Overview
• Exhibits101: Camber Pharmaceuticals Inc. - Product / Service
• Exhibits102: Camber Pharmaceuticals Inc. - Key offerings
• Exhibits103: Cipla Ltd. - Overview
• Exhibits104: Cipla Ltd. - Business segments
• Exhibits105: Cipla Ltd. - Key news
• Exhibits106: Cipla Ltd. - Key offerings
• Exhibits107: Cipla Ltd. - Segment focus
• Exhibits108: Genesis Biotec Inc. - Overview
• Exhibits109: Genesis Biotec Inc. - Product / Service
• Exhibits110: Genesis Biotec Inc. - Key offerings
• Exhibits111: Lupin Ltd - Overview
• Exhibits112: Lupin Ltd - Product / Service
• Exhibits113: Lupin Ltd - Key news
• Exhibits114: Lupin Ltd - Key offerings
• Exhibits115: Medley Pharmaceuticals Ltd. - Overview
• Exhibits116: Medley Pharmaceuticals Ltd. - Product / Service
• Exhibits117: Medley Pharmaceuticals Ltd. - Key offerings
• Exhibits118: MK Medicine - Overview
• Exhibits119: MK Medicine - Product / Service
• Exhibits120: MK Medicine - Key offerings
• Exhibits121: Novartis AG - Overview
• Exhibits122: Novartis AG - Business segments
• Exhibits123: Novartis AG - Key offerings
• Exhibits124: Novartis AG - Segment focus
• Exhibits125: Pfizer Inc. - Overview
• Exhibits126: Pfizer Inc. - Product / Service
• Exhibits127: Pfizer Inc. - Key news
• Exhibits128: Pfizer Inc. - Key offerings
• Exhibits129: Torrent Pharmaceuticals Ltd. - Overview
• Exhibits130: Torrent Pharmaceuticals Ltd. - Business segments
• Exhibits131: Torrent Pharmaceuticals Ltd. - Key offerings
• Exhibits132: Torrent Pharmaceuticals Ltd. - Segment focus
• Exhibits133: Inclusions checklist
• Exhibits134: Exclusions checklist
• Exhibits135: Currency conversion rates for US$
• Exhibits136: Research methodology
• Exhibits137: Validation techniques employed for market sizing
• Exhibits138: Information sources
• Exhibits139: List of abbreviations